Blinatumomab granted full approval to treat rel/ref BCP-ALLJuly 13, 2017Leukemia, Myelodysplasia, TransplantationPharmacyALL
ODAC recommends approval of CTL019 in rel/ref ALLJuly 13, 2017Leukemia, Myelodysplasia, TransplantationPediatricsALL
Mapping the genomic landscape of T-ALLJuly 6, 2017Leukemia, Myelodysplasia, TransplantationPediatricsALL
EC approves therapy for relapsed/refractory BCP-ALLJuly 4, 2017Leukemia, Myelodysplasia, TransplantationPharmacyALL
CSF p-Tau predicts neurocognitive sequelae in survivors of childhood cancerJune 28, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLNon-Hodgkin LymphomaAggressive Lymphomas
Neurotoxicity needs separate treatment from CRS in CAR T-cell therapyJune 18, 2017Leukemia, Myelodysplasia, TransplantationALL
Pembrolizumab enhances CAR T-cell persistence in relapsed ALLJune 8, 2017Leukemia, Myelodysplasia, TransplantationPediatricsALL
CAR T cells elicit durable, potent responses in kids with EM relapse of ALLJune 5, 2017Leukemia, Myelodysplasia, TransplantationPediatricsALL
Severe health conditions decrease among childhood cancer survivorsJune 4, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Differences emerge in new guidelines for managing FN in kidsJune 3, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsTransplantationAMLALLAggressive Lymphomas
First generic version of clofarabine available in USMay 18, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
Antibody shows potential for treating AML, B-ALLMay 16, 2017Leukemia, Myelodysplasia, TransplantationAMLALL
Novel inhibitor proves ‘potent’ in hematologic malignanciesMay 9, 2017AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLMyelodysplastic SyndromeHodgkin Lymphoma
FDA approves first ready-to-use oral solution of methotrexateMay 2, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
CHMP recommends inotuzumab ozogamicin for adult ALLApril 24, 2017Leukemia, Myelodysplasia, TransplantationPharmacyALL
